CCN2 and breast carcinoma: reported an increase in connective tissue growth factor (CTGF) mRNA with reduced sensitivity to tamoxifen in breast cancer cells cocultured with mammary adipocytes under conditions of high glucose, an effect that was reversed by inhibiting adipocyte-derived interleukin 8 (IL8) (65).